If left untreated, yeast infections can create considerable discomfort and pain
Consumers should also watch for red flags indicating problematic products or marketing: companies making pharmaceutical equivalence claims, dramatic before-and-after weight loss promises, proprietary blend language hiding strain disclosure, astronomical CFU counts emphasized without research context, and guarantee windows too short to allow realistic assessment (under 60 days)
In Phase III clinical trial data released last year, people on the highest dose of orforglipron lost, on average, 10% of their baseline body weight, compared to the 2.5% average weight loss seen in people taking a placebo
If you've achieved your goal weight and want to assess whether you can maintain it without medication, a gradual dose reduction under medical supervision is safer than abrupt discontinuation
What began as a promise of accessible care has morphed into a new digital frontier - one that raises a central question: Is the GLP-1 telehealth boom an innovation in patient empowerment, or the next great privacy nightmare
For many people, loose skin becomes its own source of frustration, sometimes a bigger one than the weight ever was
